136-150 of 2767
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
NeuroFrontiersIron Deposition and Cognitive Fatigue in Multiple Sclerosis
“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
The Convergence“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
Brian P. McDonough, MD, FAAFP
Kate Rouch
Inside the COVID-19 Response: Scientific Rigor Amid Uncertainty
Clinician's RoundtableInside the COVID-19 Response: Scientific Rigor Amid Uncertainty
Jason Goldman, MD
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiersAddressing the Hidden Burden of Negative Symptoms in Schizophrenia
Alexandria May, PharmD, BCPS
Michael Halassa, MD, PhD
How Muscarinic Therapies Are Redefining Schizophrenia Care
NeuroFrontiersHow Muscarinic Therapies Are Redefining Schizophrenia Care
Michael Halassa, MD, PhD
Unlocking the Potential of TYK2 Inhibitors in Plaque Psoriasis
On the Frontlines of PsoriasisUnlocking the Potential of TYK2 Inhibitors in Plaque Psoriasis
Christopher Bunick, MD, PhD, FAAD
Ryan Quigley
- advertisement
"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
The Convergence"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
Brian P. McDonough, MD, FAAFP
Clement Papadacci, PhD
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiersDetecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey A. Lieberman, MD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiersOvercoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Charles Turck, PharmD, BCPS, BCCCP
Tushita Mayanil, MBBS (MD)
Melanie Yabs, PharmD, MS, BCPP
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiersSupporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Charles Turck, PharmD, BCPS, BCCCP
Hannah Brown, MD
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiersBeyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Ashley Baker, MSN, PMHNP
Stephen Marder, MD
Modern Approaches to Long-Term Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerModern Approaches to Long-Term Metastatic Breast Cancer Care
Charles Turck, PharmD, BCPS, BCCCP
Adam Brufsky, MD, PhD
- advertisement
Recognizing Methamphetamine-Associated PAH: Strategies for Complex Care
Deep Breaths: Updates from CHESTRecognizing Methamphetamine-Associated PAH: Strategies for Complex Care
Rodolfo A. Estrada MD, FCCP
Steven M. Hollenberg, MD
Dana Kay, DO
Identifying and Managing Violence Risk in Schizophrenia Care
On the Frontlines of SchizophreniaIdentifying and Managing Violence Risk in Schizophrenia Care
Alexandria May, PharmD, BCPS
Ragy R. Girgis, MD, MS
Digital Danger: Understanding AI Psychosis in Schizophrenia
On the Frontlines of SchizophreniaDigital Danger: Understanding AI Psychosis in Schizophrenia
Alexandria May, PharmD, BCPS
Ragy R. Girgis, MD, MS
